(1H-PYRAZOL-5-YL)-2H-2-CHROMEN-2-ONE
1639
REFERENCES
1. Prakash, O.; Kumar, R.; Parkash, V. Synthesis and antifungal activity of some new
3-hydroxy-2-(1-phenyl-3-aryl-4-pyrazolyl)chromones. Eur. J. Med. Chem. 2008, 43, 435.
2. Genin, M. J.; Biles, C.; Keiser, B. J.; Poppe, S. M.; Swaney, S. M.; Tarpley, W. G.; Yagi,
Y.; Romero, D. L. Novel 1,5-diphenylpyrazole nonnucleoside HIV-1 reverse transcriptase
inhibitors with enhanced activity versus the delavirdine-resistant P236L mutant: Lead
identification and SAR of 3- and 4-substituted derivatives. J. Med. Chem. 2000, 43, 1034.
3. Vera-DiVaio, M. A. F.; Freitas, A. C. C.; Castro, H. C. A.; de Albuquerque, S.; Cabral, L.
M.; Rodrigues, C. R.; Albuquerque, M. G.; Martins, R. C. A.; Henriques, M. G.; Dias, L.
R. S. Synthesis, antichagasic in vitro evaluation, cytotoxicity assays, molecular modeling,
and SAR=QSAR studies of
a 2-phenyl-3-(1-phenyl-1H-pyrazol-4-yl)-acrylic acid
benzylidene-carbohydrazide series. Bioorg. Med. Chem. 2009, 17, 295.
4. Ahlstrom, M. M.; Ridderstrom, M.; Zamora, I.; Luthman, K. CYP2C9 Structureꢀ
metabolism relationships: Optimizing the metabolic stability of COX-2 inhibitors. J.
Med. Chem. 2007, 50, 4444.
5. Elguero, J. In Comprehensive Heterocyclic Chemistry; A. R. Katritzky, C. W. Rees, E. F.
V. Scriven (Eds.); Pergamon: Oxford, 1996; Vol. 5.
6. Pargellis, C.; Tong, L.; Churchill, L.; Cirillo, P. F.; Gilmore, T.; Graham, A. G.; Grob, P. M.;
Hickey, E. R.; Moss, N.; Pav, S.; Regan, J. Inhibition of p38 MAP kinase by utilizing a novel
allosteric binding site. Nat. Struct. Biol. 2002, 9, 268.
7. Yang, L.; Okuda, F.; Kobayashi, K.; Nozaki, K.; Tanabe, Y.; Ishii, Y.; Haga, M. Synth-
eses and phosphorescent properties of blue emissive iridium complexes with tridentate
pyrazolyl ligands. Inorg. Chem. 2008, 47, 7154.
8. Chang, S. Y.; Chen, J. L.; Chi, Y. Blue-emitting platinum(II) complexes bearing both
pyridylpyrazolate chelate and bridging pyrazolate ligands: Synthesis, structures, and
photophysical properties. Inorg. Chem. 2007, 46, 11202.
´
9. Cavero, E.; Uriel, S.; Romero, P.; Serrano, J. L.; Gimenez, R. Tetrahedral zinc complexes
with liquid crystalline and luminescent properties: Interplay between nonconventional
molecular shapes and supramolecular mesomorphic order. J. Am. Chem. Soc. 2007,
129, 11608.
10. Ye, C.; Gard, G. L.; Winter, R. W.; Syvret, R. G.; Twamley, B.; Shreeve, J. M. Synthesis of
pentafluorosulfanylpyrazole and pentafluorosulfanyl-1,2,3-triazole and their derivatives as
energetic materials by click chemistry. Org. Lett. 2007, 9, 3841.
´
´
´
11. Fustero, S.; Sanchez-Rosello, M.; Barrio, P.; Simon-Fuentes, A. From 2000 to mid-2010:
A fruitful decade for the synthesis of pyrazoles. Chem. Rev. 2011, 111, 6984.
12. Pan, X.; Luo, Y.; Wu, J. Route to pyrazolo[5,1-a]isoquinolines via a copper-catalyzed
tandem reaction of 2-alkynylbromobenzene with pyrazole. J. Org. Chem. 2013, 78, 5756.
13. Hao, W. J.; Xu, X. P.; Bai, H-W.; Wang, S. Y.; Ji, S. J. Efficient multicomponent strategy
to pentacyclic pyrazole-fused naphtho[1,8-fg]isoquinolines through cleavage of two
carbon–carbon bonds. Org. Lett. 2012, 14, 4894.
14. Robinson, T. In The Organic Constituents of Higher Plants: Their Chemistry and
Interrelationships; T. Robinson (Ed.); Burgess: Minneapolis, MN, 1967.
15. Borah, P.; Naidu, P. S.; Bhuyan, P. J. Synthesis of some tetrazole fused pyrido[2,3-c]
coumarin derivatives from a one-pot three-component reaction via intramolecular
1,3-dipolar cycloaddition reaction of azide to nitriles. Tetrahedron Lett. 2012, 53, 5034.
16. Kirkiacharian, S.; Thuy, D. T.; Sicsic, S.; Bakhchinian, R.; Kurkjian, R.; Tonnaire, T.
Structure–activity relationships of some 3-substituted-4-hydroxycoumarins as HIV-1
protease inhibitors. Farmaco 2002, 57, 703.
17. Majumdar, K. C.; Taher, A.; Ponra, P. Catalyst-free regioselective synthesis
of benzopyran-annulated thiopyrano[2,3-b]thiochromen-5-(4H)-one derivatives by